All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...
As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the ...
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...
Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders ...
When the deal closes, Endo will become a wholly owned subsidiary of Mallinckrodt. The combined company will take on a ...